Clever Culture Systems LimitedASX: CC5

PSC Biotech Partnership Expands US Pharma Sales Reach

· Issued by Clever Culture Systems Limited via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Clever Culture Systems Limited has announced a partnership with PSC Biotech to expand its sales reach in the pharmaceutical market across the United States, Canada, and Singapore. The agreement allows PSC Biotech to act as the sole sales agent for the APAS® Independence instrument, targeting regional and medium-sized pharmaceutical manufacturers. As part of the agreement, PSC Biotech will purchase one APAS® Independence instrument and establish a center of excellence at its facility in Pennsylvania. This partnership is expected to create new sales opportunities and enhance the distribution of CCS's innovative technology in the pharmaceutical sector.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Clever Culture Systems Ltd 16 Anster St Adelaide SA 5000 www.cleverculturesystems.com ASX:CC5 PSC BIOTECH PARTNERSHIP EXPANDS US PHARMA SALES REACH Adelaide, Australia, 14 October 2026: Leaders in AI microbiology automation, Clever Culture Systems Ltd (ASX: CC5) (CCS or the Company), is...

Clever Culture Systems Limited on 6ix

Earlier from Clever Culture Systems

All Clever Culture Systems news releases